Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan S Premasiri

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|October 5, 2020
Type I PRMT Inhibition Protects Against C9ORF72 Arginine-Rich Dipeptide Repeat ToxicityAlan S Premasiri, Anna L Gill, Fernando G Vieira
Frontiers in Cellular Neuroscience|April 9, 2021
Hypothesis and Theory: Roles of Arginine Methylation in C9orf72-Mediated ALS and FTDAnna L Gill, Alan S Premasiri, Fernando G Vieira
NPJ Digital Medicine|April 9, 2022
A machine-learning based objective measure for ALS disease severityFernando G Vieira, Subhashini Venugopalan, Alan S Premasiri, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|October 5, 2020
Type I PRMT Inhibition Protects Against C9ORF72 Arginine-Rich Dipeptide Repeat ToxicityAlan S Premasiri, Anna L Gill, Fernando G Vieira
Frontiers in Cellular Neuroscience|April 9, 2021
Hypothesis and Theory: Roles of Arginine Methylation in C9orf72-Mediated ALS and FTDAnna L Gill, Alan S Premasiri, Fernando G Vieira
NPJ Digital Medicine|April 9, 2022
A machine-learning based objective measure for ALS disease severityFernando G Vieira, Subhashini Venugopalan, Alan S Premasiri, et al.
Pageof 1